THYMOGLOBULIN PLUS BASILIXIMAB VERSUS BASILIXIMAB INDUCTION IN DECEASED DONOR KIDNEY TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS AND MMF: 1-YEAR RESULTS OF A PROSPECTIVE CLINICAL TRIAL

被引：0
|
作者：
Favi, Evaldo
Spagnoletti, Gionata
Silvestrini, Nicola
Salerno, Maria P.
Pedroso, Jose A.
Romagnoli, Jacopo
Citterio, Franco
机构：
来源：
TRANSPLANT INTERNATIONAL | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [31] Low-Dose Thymoglobulin versus Basiliximab Induction Therapy in Low-Risk Living Related Kidney Transplant Recipients: Three-Year Follow-Up Study
    Martinez-Mier, Gustavo
    Moreno-Ley, Pedro I.
    Budar-Fernandez, Luis F.
    Mendez-Lopez, Marco T.
    Allende-Castellanos, Carlos A.
    Jimenez-Lopez, Luis A.
    Barrera-Amoros, Daniel A.
    Reyes-Ruiz, Jose Manuel
    ARCHIVES OF MEDICAL RESEARCH, 2024, 55 (06)
  • [32] A prospective randomised study from Eastern India comparing Basiliximab versus no induction immunosuppression in low immunological risk kidney transplant recipients
    Gosain, Varun
    Rout, Shashibhushan
    TRANSPLANTATION, 2024, 108 (09) : 718 - 718
  • [33] A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial
    Ishida, Hideki
    Takahara, Shiro
    Amada, Noritoshi
    Tomikawa, Shinji
    Chikaraishi, Tatsuya
    Takahashi, Kota
    Uchida, Kazuhiro
    Akiyama, Takahiro
    Tanabe, Kazunari
    Toma, Hiroshi
    Experimental and Clinical Transplantation, 2016, 14 (05) : 518 - 525
  • [34] THE INITIAL RESULTS OF THE DECEASED DONOR KIDNEY TRANSPLANTATION AFTER INDUCTION OF ANTI-THYMOCYTE GLOBULIN (ATG) VERSUS BASILIXIMAB FROM THE NEW KOREAN KIDNEY TRANSPLANTATION CENTER
    Ju, Ik Moon
    Seong, Uk Cheon
    In, Seok Choi
    TRANSPLANT INTERNATIONAL, 2015, 28 : 368 - 368
  • [35] Ten-year Follow-up of Basiliximab Induction Therapy for Live-donor Kidney Transplant: A Prospective Randomized Controlled Study
    Sheashaa, Hussein A.
    Bakr, Mohamed A.
    Rashad, Rashad H.
    Ismail, Amani M.
    Sobh, Mohamed A.
    Ghoneim, Mohamed A.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2011, 9 (04) : 247 - 251
  • [36] Opportunistic Viral Infections After Alemtuzumab Induction: Results From a Randomized Controlled Trial (RCT) Comparing Alemtuzumab and Basiliximab Induction in Kidney Transplant Recipients (KTRs).
    Cherukuri, A.
    Welberry-Smith, M.
    Saundh, B.
    Hale, A.
    Baker, R.
    TRANSPLANTATION, 2014, 98 : 536 - 536
  • [37] Opportunistic Viral Infections After Alemtuzumab Induction: Results From a Randomized Controlled Trial (RCT) Comparing Alemtuzumab and Basiliximab Induction in Kidney Transplant Recipients (KTRs)
    Cherukuri, A.
    Welberry-Smith, M.
    Saundh, B.
    Hale, A.
    Baker, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 536 - 536
  • [38] Results of the Ctot19 Trial: Infliximab (IFX) Induction Does Not Impact 2-Year Outcomes in Deceased Donor Kidney Transplant Recipients
    Heeger, P.
    Armstrong, B.
    Alhamad, T.
    Brennan, D.
    Bromberg, J.
    Bunnapradist, S.
    Chandran, S.
    Fairchild, R.
    Foley, D.
    Formica, R.
    Gibson, I. W.
    Hricik, D.
    Kesler, K.
    Mannon, R. B.
    Menon, M.
    Newell, K.
    Nickerson, P.
    Odim, J.
    Poggio, E.
    Sung, R.
    Shapiro, R.
    Tinckam, K.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 594 - 594
  • [39] Two-year outcomes of thymoglobulin versus basiliximab induction combined with sirolimus and reduced-dose cyclosporine (CsA) for high versus low risk immune responder renal transplant recipients.
    Knight, RJ
    Kerman, RH
    Schoenberg, L
    Podder, H
    Katz, SM
    Van Buren, CT
    Kahan, BD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 188 - 188
  • [40] The Combination of Everolimus and Low Dose Cyclosporine Allows Similar Results as the Standard Tacrolimus and MMF Regimen: 3-Year Results of a Prospective Clinical Trial in Renal Transplant Recipients
    Favi, Evaldo
    Spagnoletti, Gionata
    Gargiulo, Antonio
    Romagnoli, Jacopo
    Castagneto, Marco
    Citterio, Franco
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 506 - 506
12345